These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; GarcĂa-Cambero JP; Zaragoza O Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099 [TBL] [Abstract][Full Text] [Related]
28. The Anticancer Drug Bleomycin Shows Potent Antifungal Activity by Altering Phospholipid Biosynthesis. Pokharel M; Konarzewska P; Roberge JY; Han GS; Wang Y; Carman GM; Xue C Microbiol Spectr; 2022 Oct; 10(5):e0086222. PubMed ID: 36036637 [TBL] [Abstract][Full Text] [Related]
29. Elucidating drug resistance in human fungal pathogens. Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351 [TBL] [Abstract][Full Text] [Related]
30. Two plant-derived aporphinoid alkaloids exert their antifungal activity by disrupting mitochondrial iron-sulfur cluster biosynthesis. Tripathi SK; Xu T; Feng Q; Avula B; Shi X; Pan X; Mask MM; Baerson SR; Jacob MR; Ravu RR; Khan SI; Li XC; Khan IA; Clark AM; Agarwal AK J Biol Chem; 2017 Oct; 292(40):16578-16593. PubMed ID: 28821607 [TBL] [Abstract][Full Text] [Related]
31. Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates. Montoya MC; Beattie S; Alden KM; Krysan DJ Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907188 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid. Al Jalali V; Sauermann R; Eberl S; Zeitlinger M Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316 [TBL] [Abstract][Full Text] [Related]
37. Amino acid-derived 1,2-benzisothiazolinone derivatives as novel small-molecule antifungal inhibitors: identification of potential genetic targets. Alex D; Gay-Andrieu F; May J; Thampi L; Dou D; Mooney A; Groutas W; Calderone R Antimicrob Agents Chemother; 2012 Sep; 56(9):4630-9. PubMed ID: 22687516 [TBL] [Abstract][Full Text] [Related]
38. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
39. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726 [TBL] [Abstract][Full Text] [Related]
40. Discovery of a Novel Dibromoquinoline Compound Exhibiting Potent Antifungal and Antivirulence Activity That Targets Metal Ion Homeostasis. Mohammad H; Elghazawy NH; Eldesouky HE; Hegazy YA; Younis W; Avrimova L; Hazbun T; Arafa RK; Seleem MN ACS Infect Dis; 2018 Mar; 4(3):403-414. PubMed ID: 29370698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]